Author:
Mistry P,Plumb J,Eccles S,Watson S,Dale I,Ryder H,Box G,Charlton P,Templeton D,Bevan P B
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Boesch, D., Gaveriaux, C., Jachez, B., Pourtier-Manzanedo, A., Bollinger, P. & Loor, F. (1991). In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumour cells with SDZ PSC 833. Cancer Res 51: 4226–4233.
2. Childs, S. & Ling, V. (1994). The MDR superfamily of genes and its biological implications. In Important Advances in Oncology, De Vita VT, Hellman S and Rosenberg SA (eds), pp. 21–36. Lippincott Co: Philadelphia
3. Colombo, T., Paz, O. G. & D’Incalci, M. (1996). Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia. Br J Cancer 73: 866–871.
4. Cros, S., Guilbaud, N., Berlion, M., Dunn, T., Regnier, G., Dhainaut, A., Atassi, G. & Bizzari, J. P. (1992). In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S9788 in P388/VCR leukaemia model. Cancer Chemother Pharmacol 30: 491–494.
5. Dale, I. L., Tuffley, W., Callaghan, R., Holmes, J. A., Martin, K., Luscombe, M., Mistry, P., Ryder, H., Stewart, A. J., Charlton, P., Twentyman, P. R. & Bevan, P. (1998). Reversal of P-glycoprotein (P-gp)-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative. Br J Cancer 78: 885–892.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献